Insufficient acidification of autophagosomes facilitates group a streptococcus survival and growth in endothelial cells

mBio

Volumn 6, Issue 5, 2015, Pages

  Lu, Shiou Ling ^a,b   Kuo, Chih Feng ^c   Chen, Hao Wen ^a   Yang, Yi Shuan ^a   Liu, Ching Chuan ^d,e   Anderson, Robert ^f   Wu, Jiunn Jong ^a,e   Lin, Yee Shin ^a,e  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b OSAKA UNIVERSITY   (Japan)

^c I SHOU UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^f DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; LC3 PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MARKER; STREPTOLYSIN O; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL PROTEIN; STREPTOLYSIN;

ACIDIFICATION; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERIAL REPRODUCTION; BACTERIAL SURVIVAL; CELL PH; CELL VACUOLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR KILLING; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; CELL LINE; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PH; PHAGOSOME; PHYSIOLOGY; STREPTOCOCCUS PYOGENES;

BACTERIAL PROTEINS; CELL LINE; ENDOTHELIAL CELLS; EPITHELIAL CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MICROBIAL VIABILITY; PHAGOSOMES; STREPTOCOCCUS PYOGENES; STREPTOLYSINS; VIRULENCE FACTORS;

EID: 84946616110     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01435-15     Document Type: Article

References (57)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685-694. http://dx.doi.org/10.1016/S1473-3099(05)70267-X.
2. Cole JN, Barnett TC, Nizet V, Walker MJ. 2011. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 9:724-736. http://dx.doi.org/10.1038/nrmicro2648.
3. Friães A, Lopes JP, Melo-Cristino J, Ramirez M, the Portuguese Group for the Study of Streptococcal Infections. 2013. Changes in Streptococcus pyogenes causing invasive disease in Portugal: evidence for superantigen gene loss and acquisition. Int J Med Microbiol 303:505-513. http://dx.doi.org/10.1016/j.ijmm.2013.07.004.
4. Nasser W, Beres SB, Olsen RJ, Dean MA, Rice KA, Long SW, Kristinsson KG, Gottfredsson M, Vuopio J, Raisanen K, Caugant DA, Steinbakk M, Low DE, McGeer A, Darenberg J, Henriques-Normark B, Van Beneden CA, Hoffmann S, Musser JM. 2014. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A 111: E1768-E1776. http://dx.doi.org/10.1073/pnas.1403138111.
5. Steer AC, Lamagni T, Curtis N, Carapetis JR. 2012. Invasive group A streptococcal disease: epidemiology, pathogenesis and management. Drugs 72:1213-1227. http://dx.doi.org/10.2165/11634180-000000000-00000.
6. Dombek PE, Cue D, Sedgewick J, Lam H, Ruschkowski S, Finlay BB, Cleary PP. 1999. High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements. Mol Microbiol 31:859-870. http://dx.doi.org/10.1046/j.1365-2958.1999.01223.x.
7. Kwinn LA, Nizet V. 2007. How group A streptococcus circumvents host phagocyte defenses. Future Microbiol 2:75-84. http://dx.doi.org/10.2217/17460913.2.1.75.
8. Nizet V. 2007. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol 120:13-22. http://dx.doi.org/10.1016/j.jaci.2007.06.005.
9. Smeesters PR, McMillan DJ, Sriprakash KS. 2010. The streptococcal M protein: a highly versatile molecule. Trends Microbiol 18:275-282. http://dx.doi.org/10.1016/j.tim.2010.02.007.
10. Balaji K, Thenmozhi R, Prajna L, Dhananjeyan G, Pandian SK. 2013. Comparative analysis of emm types, superantigen gene profiles and antibiotic resistance genes among Streptococcus pyogenes isolates from ocular infections, pharyngitis and asymptomatic children in south India. Infect Genet Evol 19:105-112. http://dx.doi.org/10.1016/j.meegid.2013.06.018.
11. Hertzén E, Johansson L, Wallin R, Schmidt H, Kroll M, Rehn AP, Kotb M, Mörgelin M, Norrby-Teglund A. 2010. M1 protein-dependent intracellular trafficking promotes persistence and replication of Streptococcus pyogenes in macrophages. J Innate Immun 2:534-545. http://dx.doi.org/10.1159/000317635.
12. Medina E, Rohde M, Chhatwal GS. 2003. Intracellular survival of Streptococcus pyogenes in polymorphonuclear cells results in increased bacterial virulence. Infect Immun 71:5376-5380. http://dx.doi.org/10.1128/IAI.71.9.5376-5380.2003.
13. Thulin P, Johansson L, Low DE, Gan BS, Kotb M, McGeer A, Norrby-Teglund A. 2006. Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med 3:e53. http://dx.doi.org/10.1371/journal.pmed.0030053.
14. Hamasaki M, Furuta N, Matsuda A, Nezu A, Yamamoto A, Fujita N, Oomori H, Noda T, Haraguchi T, Hiraoka Y, Amano A, Yoshimori T. 2013. Autophagosomes form at ER-mitochondria contact sites. Nature 495:389-393. http://dx.doi.org/10.1038/nature11910.
15. Chua CEL, Tang BL. 2013. Linking membrane dynamics and trafficking to autophagy and the unfolded protein response. J Cell Physiol 228: 1638-1640. http://dx.doi.org/10.1002/jcp.24341.
16. Fujita N, Morita E, Itoh T, Tanaka A, Nakaoka M, Osada Y, Umemoto T, Saitoh T, Nakatogawa H, Kobayashi S, Haraguchi T, Guan JL, Iwai K, Tokunaga F, Saito K, Ishibashi K, Akira S, Fukuda M, Noda T, Yoshimori T. 2013. Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. J Cell Biol 203:115-128. http://dx.doi.org/10.1083/jcb.201304188.
17. Maejima I, Takahashi A, Omori H, Kimura T, Takabatake Y, Saitoh T, Yamamoto A, Hamasaki M, Noda T, Isaka Y, Yoshimori T. 2013. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J 32:2336-2347. http://dx.doi.org/10.1038/emboj.2013.171.
18. Twig G, Hyde B, Shirihai OS. 2008. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochem Biophys Acta 1777:1092-1097. http://dx.doi.org/10.1016/j.bbabio.2008.05.001.
19. Cemma M, Brumell JH. 2012. Interactions of pathogenic bacteria with autophagy systems. Curr Biol 22:R540-R545. http://dx.doi.org/10.1016/j.cub.2012.06.001.
20. Levine B, Mizushima N, Virgin HW. 2011. Autophagy in immunity and inflammation. Nature 469:323-335. http://dx.doi.org/10.1038/nature09782.
21. Mostowy S. 2013. Autophagy and bacterial clearance: a not so clear picture. Cell Microbiol 15:395-402. http://dx.doi.org/10.1111/cmi.12063.
22. Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, Kamimoto T, Nara A, Funao J, Nakata M, Tsuda K, Hamada S, Yoshimori T. 2004. Autophagy defends cells against invading group A streptococcus. Science 306:1037-1040. http://dx.doi.org/10.1126/science.1103966.
23. Hernandez LD, Pypaert M, Flavell RA, Galán JE. 2003. A Salmonella protein causes macrophage cell death by inducing autophagy. J Cell Biol 163:1123-1131. http://dx.doi.org/10.1083/jcb.200309161.
24. Yu HB, Croxen MA, Marchiando AM, Ferreira RB, Cadwell K, Foster LJ, Finlay BB. 2014. Autophagy facilitates Salmonella replication in HeLa cells. mBio 5:e00865-14. http://dx.doi.org/10.1128/mBio.00865-14.
25. Saftig P, Klumperman J. 2009. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol 10: 623-635. http://dx.doi.org/10.1038/nrm2745.
26. Huotari J, Helenius A. 2011. Endosome maturation. EMBO J 30: 3481-3500. http://dx.doi.org/10.1038/emboj.2011.286.
27. Amano A, Nakagawa I, Yoshimori T. 2006. Autophagy in innate immunity against intracellular bacteria. J Biochem 140:161-166. http://dx.doi.org/10.1093/jb/mvj162.
28. Nozawa T, Aikawa C, Goda A, Maruyama F, Hamada S, Nakagawa I. 2012. The small GTPases Rab9A and Rab23 function at distinct steps in autophagy during group A streptococcus infection. Cell Microbiol 14: 1149-1165. http://dx.doi.org/10.1111/j.1462-5822.2012.01792.x.
29. Sakurai A, Maruyama F, Funao J, Nozawa T, Aikawa C, Okahashi N, Shintani S, Hamada S, Ooshima T, Nakagawa I. 2010. Specific behavior of intracellular Streptococcus pyogenes that has undergone autophagic degradation is associated with bacterial streptolysin O and host small G proteins Rab5 and Rab7. J Biol Chem 285:22666-22675. http://dx.doi.org/10.1074/jbc.M109.100131.
30. Barnett TC, Liebl D, Seymour LM, Gillen CM, Lim JY, LaRock CN, Davies MR, Schulz BL, Nizet V, Teasdale RD, Walker MJ. 2013. The globally disseminated M1T1 clone of group A streptococcus evades autophagy for intracellular replication. Cell Host Microbe 14:675-682. http://dx.doi.org/10.1016/j.chom.2013.11.003.
31. Amelung S, Nerlich A, Rohde M, Spellerberg B, Cole JN, Nizet V, Chhatwal GS, Talay SR. 2011. The FbaB-type fibronectin-binding protein of Streptococcus pyogenes promotes specific invasion into endothelial cells. Cell Microbiol 13:1200-1211. http://dx.doi.org/10.1111/j.1462-5822.2011.01610.x.
32. Nerlich A, Rohde M, Talay SR, Genth H, Just I, Chhatwal GS. 2009. Invasion of endothelial cells by tissue-invasive M3 type group A streptococci requires Src kinase and activation of Rac1 by a phosphatidylinositol 3-kinase-independent mechanism. J Biol Chem 284:20319-20328. http://dx.doi.org/10.1074/jbc.M109.016501.
33. Ochel A, Rohde M, Chhatwal GS, Talay SR. 2014. The M1 protein of Streptococcus pyogenes triggers an innate uptake mechanism into polarized human endothelial cells. J Innate Immun 6:585-596. http://dx.doi.org/10.1159/000358085.
34. O’Seaghdha M, Wessels MR. 2013. Streptolysin O and its co-toxin NADglycohydrolase protect group A streptococcus from xenophagic killing. PLoS Pathog 9:e1003394.http://dx.doi.org/10.1371/journal.ppat.1003394.
35. Bastiat-Sempe B, Love JF, Lomayesva N, Wessels MR. 2014. Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages. mBio 5:e01690-14. http://dx.doi.org/10.1128/mBio.01690-14.
36. Nakamura T, Hasegawa T, Torii K, Hasegawa Y, Shimokata K, Ohta M. 2004. Two-dimensional gel electrophoresis analysis of the abundance of virulent exoproteins of group A streptococcus caused by environmental changes. Arch Microbiol 181:74-81. http://dx.doi.org/10.1007/s00203-003-0632-6.
37. Feldman-Salit A, Hering S, Messiha HL, Veith N, Cojocaru V, Sieg A, Westerhoff HV, Kreikemeyer B, Wade RC, Fiedler T. 2013. Regulation of the activity of lactate dehydrogenases from four lactic acid bacteria. J Biol Chem 288:21295-21306. http://dx.doi.org/10.1074/jbc.M113.458265.
38. Antunes LC, McDonald JA, Schroeter K, Carlucci C, Ferreira RB, Wang M, Yurist-Doutsch S, Hira G, Jacobson K, Davies J, Allen-Vercoe E, Finlay BB. 2014. Antivirulence activity of the human gut metabolome. mBio 5:e01183-14. http://dx.doi.org/10.1128/mBio.01183-14.
39. Cohen JO. 1969. Effect of culture medium composition and pH on the production ofMprotein and proteinase by group A streptococci. J Bacteriol 99:737-744.
40. Wood DN, Weinstein KE, Podbielski A, Kreikemeyer B, Gaughan JP, Valentine S, Buttaro BA. 2009. Generation of metabolically diverse strains of Streptococcus pyogenes during survival in stationary phase. J Bacteriol 191:6242-6252. http://dx.doi.org/10.1128/JB.00440-09.
41. Savic DJ, McShan WM. 2012. Long-term survival of Streptococcus pyogenes in rich media is pH-dependent. Microbiology 158:1428-1436. http://dx.doi.org/10.1099/mic.0.054478-0.
42. Loughman JA, Caparon M. 2006. Regulation of SpeB in Streptococcus pyogenes by pH and NaCl: a model for in vivo gene expression. J Bacteriol 188:399-408. http://dx.doi.org/10.1128/JB.188.2.399-408.2006.
43. Chiang-Ni C, Zheng PX, Tsai PJ, Chuang WJ, Lin YS, Liu CC, Wu JJ. 2012. Environmental pH changes, but not the LuxS signalling pathway, regulate SpeB expression in M1 group A streptococci. J Med Microbiol 61:16-22. http://dx.doi.org/10.1099/jmm.0.036012-0.
44. Tatsuno I, Isaka M, Minami M, Hasegawa T. 2010. NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A streptococcal isolates. BMC Microbiol 10:144. http://dx.doi.org/10.1186/1471-2180-10-144.
45. Nelson DC, Garbe J, Collin M. 2011. Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins. Biol Chem 392:1077-1088. http://dx.doi.org/10.1515/BC.2011.208.
46. Kinchen JM, Ravichandran KS. 2008. Phagosome maturation: going through the acid test. Nat Rev Mol Cell Biol 9:781-795. http://dx.doi.org/10.1038/nrm2515.
47. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y. 1998. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4 II-E cells. Cell Struct Funct 23:33-42. http://dx.doi.org/10.1247/csf.23.33.
48. Fiedler T, Kreikemeyer B, Sugareva V, Redanz S, Arlt R, Standar K, Podbielski A. 2010. Impact of the Streptococcus pyogenes Mga regulator on human matrix protein binding and interaction with eukaryotic cells. Int J Med Microbiol 300:248-258. http://dx.doi.org/10.1016/j.ijmm.2009.07.004.
49. Nordenfelt P, Grinstein S, Björck L, Tapper H. 2012. V-ATPasemediated phagosomal acidification is impaired by Streptococcus pyogenes through Mga-regulated surface proteins. Microbes Infect 14:1319-1329. http://dx.doi.org/10.1016/j.micinf.2012.08.005.
50. Huang J, Brumell JH. 2014. Bacteria-autophagy interplay: a battle for survival. Nat Rev Microbiol 12:101-114. http://dx.doi.org/10.1038/nrmicro3160.
51. Kuo CF, Wu JJ, Lin KY, Tsai PJ, Lee SC, Jin YT, Lei HY, Lin YS. 1998. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun 66:3931-3935.
52. Lai S, Devenish RJ. 2012. LC3-associated phagocytosis (LAP): connections with host autophagy. Cells 1:396-408. http://dx.doi.org/10.3390/cells1030396.
53. Kageyama S, Omori H, Saitoh T, Sone T, Guan JL, Akira S, Imamoto F, Noda T, Yoshimori T. 2011. The LC3 recruitment mechanism is separate from Atg9L1-dependent membrane formation in the autophagic response against Salmonella. Mol Biol Cell 22:2290-2300. http://dx.doi.org/10.1091/mbc.E10-11-0893.
54. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ. 1992. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99:683-690. http://dx.doi.org/10.1111/1523-1747.ep12613748.
55. Hung CH, Tsao N, Zeng YF, Lu SL, Chiang-Ni C, Lin YS, Wu JJ, Kuo CF. 2012. Synergistic effects of streptolysin S and streptococcal pyrogenic exotoxin B on the mouse model of group A streptococcal infection. Med Microbiol Immunol 201:357-369. http://dx.doi.org/10.1007/s00430-012-0241-6.
56. Podbielski A, Flosdorff A, Weber-Heynemann J. 1995. The group A streptococcal virR49 gene controls expression of four structural vir regulon genes. Infect Immun 63:9-20.
57. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. http://dx.doi.org/10.1093/nar/29.9.e45.